Search
Theravance Biopharma Inc
TBPHAdd to Watchlist
16.930USD
-0.050-0.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
872.15MMarket Cap
7.42P/E TTM
Theravance Biopharma Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Theravance Biopharma Inc is 7.33, ranking 131 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 7.42, which is 713.32% below the recent high of 60.35 and 345.81% above the recent low of -18.24.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.